CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 28 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 25.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $13,000 | 0.0% | 4,300 | 0.0% | 0.00% | – |
Q2 2014 | $13,000 | -18.8% | 4,300 | 0.0% | 0.00% | – |
Q1 2014 | $16,000 | -5.9% | 4,300 | 0.0% | 0.00% | – |
Q4 2013 | $17,000 | -5.6% | 4,300 | 0.0% | 0.00% | – |
Q3 2013 | $18,000 | -21.7% | 4,300 | -44.2% | 0.00% | – |
Q2 2013 | $23,000 | – | 7,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 2,356,091 | $1,202,000 | 0.05% |
VANGUARD GROUP INC | 6,177,466 | $156,921,000 | 0.01% |
SHUFRO ROSE & CO LLC | 17,500 | $8,000 | 0.00% |
LEAVELL INVESTMENT MANAGEMENT, INC. | 12,000 | $6,000 | 0.00% |
PACIFIC GLOBAL INVESTMENT MANAGEMENT CO | 10,000 | $5,000 | 0.00% |
Glassman Wealth Services | 2,197 | $1,000 | 0.00% |
Krilogy Financial LLC | 600 | $1,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 5,856 | $3,000 | 0.00% |
NORTHERN TRUST CORP | 33,166 | $17,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 86,435 | $44,000 | 0.00% |